N4 Pharma (“N4P”) has raised £1.75m (gross) new funding through an equity placing and subscription (‘the Fundraising Shares’) priced at 0.40p/share (representing a 5.9% discount to Monday’s close). Each placing and subscription share will have one warrant attached, exercisable at 0.8p for a period of three years from the second admission date. 142.78m of the Fundraise Shares have been issued utilising the Group’s existing authorities, while 294.72m shares will be issued subject to shareholder approval at a General Meeting to be held in the coming weeks, as will be the issuance and exercise of all warrants.